Related Experiment Video
Updated: May 17, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Joint models in big data: simulation-based guidelines for required data quality in longitudinal electronic health
Berit Hunsdieck1,2, Christian Bender3, Katja Ickstadt4,5
1Computational Biology, Bayer AG, Wuppertal, Germany. berit.hunsdieck@bayer.com.
Background:
Over the past decade an increase in usage of electronic health data (EHR) by office-based physicians and hospitals has been reported. However, these data types come with challenge regarding completeness and data quality and it is, especially for more complex models, unclear how these characteristics influence the performance.
Methods:
In this paper, we focus on joint models which combines longitudinal modelling with survival modelling to incorporate all available information. The aim of this paper is to establish simulation-based guidelines for the necessary quality of longitudinal EHR data so that joint models perform better than cox models. We conducted an extensive simulation study by systematically and transparently varying different characteristics of data quality, e.g., measurement frequency, noise, and heterogeneity between patients. We apply the joint models and evaluate their performance relative to traditional Cox survival modelling techniques.
Results:
Key findings suggest that biomarker changes before disease onset must be consistent within similar patient groups. With increasing noise and a higher measurement density, the joint model surpasses the traditional Cox regression model in terms of model performance. We illustrate the usefulness and limitations of the guidelines with two real-world examples, namely the influence of serum bilirubin on primary biliary liver cirrhosis and the influence of the estimated glomerular filtration rate on chronic kidney disease.
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Physiological Models
Mechanistic Models: Compartment Models in Individual and Population Analysis
Longitudinal Studies
Overview of Biostatistics in Health Sciences

